Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle
基于纳米抗体的溶瘤疱疹病毒重靶向消除 CXCR4+ GBM 细胞:原理证明
期刊:Molecular Therapy-Oncolytics
影响因子:5.3
doi:10.1016/j.omto.2022.06.002
Judit Sanchez Gil, Maxime Dubois, Virginie Neirinckx, Arnaud Lombard, Natacha Coppieters, Paolo D'Arrigo, Damla Isci, Therese Aldenhoff, Benoit Brouwers, Cédric Lassence, Bernard Rogister, Marielle Lebrun, Catherine Sadzot-Delvaux